Funds holding Realcan Pharmaceutical Group Co Ltd
ISIN CNE1000013X5 · China · LEI 300300YI5IV3FBRRSJ48
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 1.1M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 1,436,010 | 671.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 834,100 | 390.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 47,900 | 22.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 25,300 | 11.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | -1 | 2,343,310 | -4.1 % |
| 2026Q1 | 5 | 0 | 2,442,910 | 0.0 % |
| 2025Q4 | 5 | -2 | 2,442,910 | -3.5 % |
| 2025Q3 | 7 | 0 | 2,531,710 | 0.0 % |
| 2025Q2 | 7 | -1 | 2,531,710 | -1.7 % |
| 2025Q1 | 8 | -3 | 2,576,310 | -47.0 % |
| 2024Q4 | 11 | 0 | 4,863,710 | 0.0 % |
| 2024Q3 | 11 | -2 | 4,863,710 | -7.5 % |
| 2024Q2 | 13 | +4 | 5,260,210 | +236.0 % |
| 2024Q1 | 9 | 0 | 1,565,700 | -60.1 % |
| 2023Q4 | 9 | 3,924,310 |
Cite this page
Titelia. "Funds holding Realcan Pharmaceutical Group Co Ltd". https://titelia.com/en/stocks/realcan-pharmaceutical-group-co-ltd-CNE1000013X5